Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220013087 220007534 1.7 63 null 2016-01-08 2016-01-10 CYTARABINE N N 220029068 CYTARABINE
220013088 220014147 1.71 57.3 Disease modification (D) null 2015-03-02 AML MyeChild 01 FLA-Idarubicin N N 220029069 NOT MATCHED
220013090 220007536 null 65.5 Palliative (P) 2015-08-25 2015-12-20 Cytarabine Low Dose 02 N 220029078 CYTARABINE
220013091 220007537 1.6 22.7 Curative (C) 2013-11-29 2013-12-04 AML Relapsed FLA - DaunoXome N N 220029081 NOT MATCHED
220013092 220014149 1.66 9.5 Palliative (P) 2017-04-25 2017-05-09 CYTARABINE + ETOPOSIDE + MITOXANTRONE N N 220029081 NOT MATCHED
220013093 220014149 null 0 Disease modification (D) 2014-04-03 2014-04-03 Hydroxycarbamide N null 220029081 HYDROXYCARBAMIDE
220013094 220014149 null null Curative (C) 2016-04-13 2016-04-13 Hydroxycarbamide N N 220029081 HYDROXYCARBAMIDE
220013095 220007538 null 10 Disease modification (D) 2014-10-22 2014-10-27 AML MyeChild 01 A Mitozantrone/Cytarabine N N 220029091 NOT MATCHED
220013096 220007540 1.25 0 Palliative (P) 2014-04-12 2014-04-16 Hydroxycarbamide N N 220029092 HYDROXYCARBAMIDE
220013097 220007541 null 87.8 Curative (C) 2012-09-30 2013-06-07 Cytarabine Low Dose N N 220029095 CYTARABINE
220013098 220007542 1.78 null Curative (C) 2014-05-11 2014-05-14 CYTARABINE 2 N 220029096 CYTARABINE
220013099 220007544 0 null Disease modification (D) null 2018-10-19 Hydroxycarbamide N N 220029098 HYDROXYCARBAMIDE
220013100 220007545 0 62.8 Curative (C) 2015-08-11 2015-08-11 Hydroxycarbamide N N 220029102 HYDROXYCARBAMIDE
220013101 220007546 1.76 53.6 Disease modification (D) null 2015-05-05 Hydroxycarbamide N N 220029103 HYDROXYCARBAMIDE
220013102 220007547 null 34.25 Palliative (P) 2016-06-30 2016-08-18 Hydroxycarbamide 2 N 220029109 HYDROXYCARBAMIDE
220013103 220007547 null null Disease modification (D) null 2014-01-08 Cytarabine Low Dose N null 220029109 CYTARABINE
220013104 220007547 0 54 Curative (C) 2017-07-31 2017-08-04 Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE 02 N 220029109 NOT MATCHED
220013105 220007549 null null Palliative (P) 2014-04-23 2014-04-23 Cytarabine low (10to20mg/m2) IV/SC N N 220029118 CYTARABINE
220013106 220007551 null null Disease modification (D) null 2015-08-01 CYTARABINE 2 N 220029122 CYTARABINE
220013107 220007551 1.62 8.6 Palliative (P) 2016-12-02 2016-12-04 null 02 null 220029122 NOT MATCHED
220013109 220007557 1.69 null Disease modification (D) 2013-09-06 2013-09-06 Hydroxycarbamide 02 N 220029145 HYDROXYCARBAMIDE
220013110 220007557 1.25 43 null 2013-09-20 2013-09-21 ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE 02 null 220029145 NOT MATCHED
220013111 220007557 1.52 50 Palliative (P) 2016-04-10 2016-04-10 CYTARABINE N N 220029145 CYTARABINE
220013112 220007558 null 0 Disease modification (D) 2016-05-13 2016-05-14 Hydroxycarbamide 02 N 220029150 HYDROXYCARBAMIDE
220013113 220007559 null 62.8 Palliative (P) 2018-09-02 2018-09-02 Hydroxycarbamide 02 N 220029152 HYDROXYCARBAMIDE
220013114 220007560 null 0 Palliative (P) 2017-10-26 2017-11-10 NB HRNBL-1 COJEC Ind COURSE B N N 220029155 NOT MATCHED
220013115 220007561 1.08 81.7 Disease modification (D) 2018-09-17 2018-09-17 Hydroxycarbamide 2 N 220029155 HYDROXYCARBAMIDE
220013116 220017721 null 63.3 Palliative (P) 2014-04-25 2014-09-02 Hydroxycarbamide N Y 220029163 HYDROXYCARBAMIDE
220013119 220017723 1.53 87.5 Curative (C) 2013-05-04 2013-11-04 Hydroxycarbamide N null 220029170 HYDROXYCARBAMIDE
220013120 220007566 null 0 Palliative (P) 2015-05-31 2015-05-31 Hydroxycarbamide 02 null 220029176 HYDROXYCARBAMIDE
220013121 220007566 1.7 64 Palliative (P) 2014-08-07 2014-08-07 Hydroxycarbamide 2 N 220029176 HYDROXYCARBAMIDE
220013122 220007566 1.76 null Curative (C) 2016-06-24 2016-09-06 CYTARABINE 02 N 220029176 CYTARABINE
220013123 220007567 1.52 59.1 null 2016-03-27 2017-04-30 Hydroxycarbamide Y N 220029179 HYDROXYCARBAMIDE
220013124 220007567 0 113 Disease modification (D) 2015-11-28 2015-11-29 Hydroxycarbamide N N 220029179 HYDROXYCARBAMIDE
220013125 220007568 1.62 43.4 Palliative (P) null 2015-08-28 Cytarabine Low Dose N N 220029185 CYTARABINE
220013126 220014166 1.04 76.4 Disease modification (D) null 2015-04-17 Enasidenib + Enasidenib N N 220029188 NOT MATCHED
220013127 220007570 1.63 68.8 Palliative (P) null 2017-10-31 CYTARABINE 2 N 220029190 CYTARABINE
220013128 220014167 1.04 18.3 Curative (C) 2014-08-01 2014-08-07 null null N 220029191 NOT MATCHED
220013129 220014167 null 66.8 Disease modification (D) 2017-05-30 2017-05-30 Hydroxycarbamide null null 220029191 HYDROXYCARBAMIDE
220013130 220014167 0 65 Disease modification (D) 2014-01-03 2014-01-04 CYTARABINE 02 N 220029191 CYTARABINE
220013132 220007572 null 51.5 Curative (C) 2013-06-17 2013-06-28 CYTARABINE N null 220029203 CYTARABINE
220013133 220007573 1.04 109.1 Palliative (P) 2017-02-22 2017-02-22 Cytarabine low (10to20mg/m2) IV/SC N N 220029205 CYTARABINE
220013134 220007574 1.59 null Palliative (P) 2015-08-16 2015-08-17 CYTARABINE null N 220029214 CYTARABINE
220013135 220007574 1.61 68 Palliative (P) 2015-11-17 2015-11-17 Hydroxycarbamide N N 220029214 HYDROXYCARBAMIDE
220013136 220007574 1.54 74.7 Not known (9) 2016-07-19 2016-07-19 CYTARABINE N null 220029214 CYTARABINE
220013137 220019721 1.6 12.3 Palliative (P) null 2014-02-13 AML Interim Guidelines FLA N null 220029230 NOT MATCHED
220013138 220007575 0 null Palliative (P) 2015-07-10 2015-07-12 CYTARABINE N N 220029232 CYTARABINE
220013139 220014169 1.79 113 Palliative (P) null 2015-06-14 Cytarabine Low Dose N N 220029234 CYTARABINE
220013140 220007577 0 8.8 Not known (9) 2013-03-23 2013-03-30 AML MyeChild 01 FLA 02 N 220029235 NOT MATCHED
220013141 220007578 1.72 80 null 2018-10-02 2018-10-10 Cytarabine Low Dose N N 220029242 CYTARABINE